These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 26535469)

  • 1. GDNF-induced cerebellar toxicity: A brief review.
    Luz M; Mohr E; Fibiger HC
    Neurotoxicology; 2016 Jan; 52():46-56. PubMed ID: 26535469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson's Disease.
    Terse PS; Kells AP; Noker P; Wright JF; Bankiewicz KS
    Int J Toxicol; 2021; 40(1):4-14. PubMed ID: 33131343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease.
    Rocco MT; Akhter AS; Ehrlich DJ; Scott GC; Lungu C; Munjal V; Aquino A; Lonser RR; Fiandaca MS; Hallett M; Heiss JD; Bankiewicz KS
    Mol Ther; 2022 Dec; 30(12):3632-3638. PubMed ID: 35957524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease.
    Kramer ER; Liss B
    FEBS Lett; 2015 Dec; 589(24 Pt A):3760-72. PubMed ID: 26555190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDNF regulates lipid metabolism and glioma growth through RET/ERK/HIF‑1/SREBP‑1.
    Yu Z; Li H; Wang M; Luo W; Xue Y
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35894143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Epithelial Barrier Maturation by Enteric Glial Cells Is GDNF-Dependent.
    Meir M; Kannapin F; Diefenbacher M; Ghoreishi Y; Kollmann C; Flemming S; Germer CT; Waschke J; Leven P; Schneider R; Wehner S; Burkard N; Schlegel N
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDNF synthesis, signaling, and retrograde transport in motor neurons.
    Cintrón-Colón AF; Almeida-Alves G; Boynton AM; Spitsbergen JM
    Cell Tissue Res; 2020 Oct; 382(1):47-56. PubMed ID: 32897420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDNF/RET signaling in dopamine neurons in vivo.
    Conway JA; Ince S; Black S; Kramer ER
    Cell Tissue Res; 2020 Oct; 382(1):135-146. PubMed ID: 32870383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDNF clinical trials for Parkinson's disease: a critical human dimension.
    Gash DM; Gerhardt GA; Bradley LH; Wagner R; Slevin JT
    Cell Tissue Res; 2020 Oct; 382(1):65-70. PubMed ID: 32830288
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular RET signaling pathways activated by GDNF.
    Kawai K; Takahashi M
    Cell Tissue Res; 2020 Oct; 382(1):113-123. PubMed ID: 32816064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.
    Barker RA; Björklund A; Gash DM; Whone A; Van Laar A; Kordower JH; Bankiewicz K; Kieburtz K; Saarma M; Booms S; Huttunen HJ; Kells AP; Fiandaca MS; Stoessl AJ; Eidelberg D; Federoff H; Voutilainen MH; Dexter DT; Eberling J; Brundin P; Isaacs L; Mursaleen L; Bresolin E; Carroll C; Coles A; Fiske B; Matthews H; Lungu C; Wyse RK; Stott S; Lang AE
    J Parkinsons Dis; 2020; 10(3):875-891. PubMed ID: 32508331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models.
    Havel V; Kruegel AC; Bechand B; McIntosh S; Stallings L; Hodges A; Wulf MG; Nelson M; Hunkele A; Ansonoff M; Pintar JE; Hwu C; Ople RS; Abi-Gerges N; Zaidi SA; Katritch V; Yang M; Javitch JA; Majumdar S; Hemby SE; Sames D
    Nat Commun; 2024 Sep; 15(1):8118. PubMed ID: 39304653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.
    Avenel ICN; Ewald JD; Ariey-Bonnet J; Kristensen IH; Petterson SA; Thesbjerg MN; Burton M; Thomassen M; Wennerberg K; Michaelsen SR; Kristensen BW
    Sci Rep; 2024 Jul; 14(1):17639. PubMed ID: 39085346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term benefits of hematopoietic stem cell-based macrophage/microglia delivery of GDNF to the CNS in a mouse model of Parkinson's disease.
    Ge G; Sivasubramanian BP; Geng BD; Zhao S; Zhou Q; Huang G; O'Connor JC; Clark RA; Li S
    Gene Ther; 2024 May; 31(5-6):324-334. PubMed ID: 38627469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding an Optimal Level of GDNF Overexpression: Insights from Dopamine Cycling.
    Marshall P
    Cell Mol Neurobiol; 2023 Oct; 43(7):3179-3189. PubMed ID: 37410316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting.
    Pawar G; Parayath NN; Sharma AA; Coito C; Khorkova O; Hsiao J; Curry WT; Amiji MM; Bleier BS
    Front Pharmacol; 2021; 12():660841. PubMed ID: 33953687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
    Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
    Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson's Disease. A Systematic Review.
    Kambey PA; Kanwore K; Ayanlaja AA; Nadeem I; Du Y; Buberwa W; Liu W; Gao D
    Front Aging Neurosci; 2021; 13():645583. PubMed ID: 33716718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial Cell Line-Derived Neurotrophic Factor and Focal Ischemic Stroke.
    Zhang Z; Sun GY; Ding S
    Neurochem Res; 2021 Oct; 46(10):2638-2650. PubMed ID: 33591443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local continuous glial cell derived neurotrophic factor release using osmotic pump promotes parasympathetic nerve rehabilitation in an animal model of cavernous nerve injury induced erectile dysfunction.
    Li H; Zhang Z; Fang D; Tang Y; Peng J
    Transl Androl Urol; 2021 Jan; 10(1):258-271. PubMed ID: 33532315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.